HAE
Haemonetics Corp
Price:  
68.92 
USD
Volume:  
968,714.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE WACC - Weighted Average Cost of Capital

The WACC of Haemonetics Corp (HAE) is 9.2%.

The Cost of Equity of Haemonetics Corp (HAE) is 10.50%.
The Cost of Debt of Haemonetics Corp (HAE) is 4.30%.

Range Selected
Cost of equity 8.80% - 12.20% 10.50%
Tax rate 15.90% - 20.10% 18.00%
Cost of debt 4.00% - 4.60% 4.30%
WACC 7.8% - 10.6% 9.2%
WACC

HAE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.08 1.32
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.80% 12.20%
Tax rate 15.90% 20.10%
Debt/Equity ratio 0.23 0.23
Cost of debt 4.00% 4.60%
After-tax WACC 7.8% 10.6%
Selected WACC 9.2%